Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- MIRA-3Independent statistical analysis of Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis (MIRA-3): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Mirabegron as Medical Expulsive Therapy (MET) for Ureteral Stones and Ureteral Stent Pain: Complete Statistical AnalysisIndependent statistical analysis of Mirabegron as Medical Expulsive Therapy (MET) for Ureteral Stones and Ureteral Stent Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MIRACLEIndependent statistical analysis of Efficacy, Safety and Tolerability of AZD9977 and Dapagliflozin in Participants With Heart Failure and Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- MIRACLE Study: A Study of Once-Monthly Intravenous Mircera in Hemodialysis Participants With Chronic Renal Anemia: Complete Statistical AnalysisIndependent statistical analysis of MIRACLE Study: A Study of Once-Monthly Intravenous Mircera in Hemodialysis Participants With Chronic Renal Anemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MIRACOLIndependent statistical analysis of Anthocyanin Extract and Phospholipid Curcumin in Colorectal Adenoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01948661).
- MiraDry TxIndependent statistical analysis of Miradry Treatment for Focal Axillary Hyperhidrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02295891).
- MIRNAIndependent statistical analysis of Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04321031).
- miRNAs, Suicide, and Ketamine – Plasma Exosomal microRNAs as Novel Biomarkers for Suicidality and Treatment Outcome: Complete Statistical AnalysisIndependent statistical analysis of miRNAs, Suicide, and Ketamine - Plasma Exosomal microRNAs as Novel Biomarkers for Suicidality and Treatment Outcome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Miromatrix Biological Mesh for Hiatal Hernia Repair: Complete Statistical AnalysisIndependent statistical analysis of Miromatrix Biological Mesh for Hiatal Hernia Repair: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02436681).
- MIRROR RCTIndependent statistical analysis of Study of KRYSTEXXA® (Pegloticase) Plus Methotrexate in Participants With Uncontrolled Gout: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- MIRROSIndependent statistical analysis of A Study of Idasanutlin With Cytarabine Versus Cytarabine Plus Placebo in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML): primary endpoint results, effect estimate with confidence interval,…
- Mirtazapine to Reduce Methamphetamine Use Among MSM With High-risk HIV Behaviors: Complete Statistical AnalysisIndependent statistical analysis of Mirtazapine to Reduce Methamphetamine Use Among MSM With High-risk HIV Behaviors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Mirtazapine Treatment of Anxiety in Children and Adolescents With Pervasive Developmental Disorders: Complete Statistical AnalysisIndependent statistical analysis of Mirtazapine Treatment of Anxiety in Children and Adolescents With Pervasive Developmental Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Mirthful Laughter and Muscle Soreness / Pain: Complete Statistical AnalysisIndependent statistical analysis of Mirthful Laughter and Muscle Soreness / Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02896075).
- MIS-ABC SepsisIndependent statistical analysis of Mechanistic Inflammatory Sub-study Embedded Within the Albumin vs Balanced Crystalloid Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- MISBLIndependent statistical analysis of Minimally Invasive Sensing of Beta-lactam Antibiotics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03847610).
- misoIndependent statistical analysis of Misoprostol Prior to Intrauterine Device (IUD) Insertion in Nulliparous Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01147497).
- MISO200Independent statistical analysis of Misoprostol 400 µg Versus 200 µg for Cervical Ripening in 1st Trimester Miscarriage: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Misoprostol for Treatment of Fetal Death at 14-28 Weeks of Pregnancy: Complete Statistical AnalysisIndependent statistical analysis of Misoprostol for Treatment of Fetal Death at 14-28 Weeks of Pregnancy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Misoprostol With Intrauterine Device Insertion: Complete Statistical AnalysisIndependent statistical analysis of Misoprostol With Intrauterine Device Insertion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00613366).
- Mission Connect Mild Traumatic Brain Injury (TBI) Integrated Clinical Protocol: Complete Statistical AnalysisIndependent statistical analysis of Mission Connect Mild Traumatic Brain Injury (TBI) Integrated Clinical Protocol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01013870).
- MISSION-Vet HUD-VASH Implementation Study: Complete Statistical AnalysisIndependent statistical analysis of MISSION-Vet HUD-VASH Implementation Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01430741).
- MississippiIndependent statistical analysis of Study Evaluating the Safety and Efficacy of NCX 4251 Ophthalmic Suspension for the Treatment of Blepharitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- MISTICIndependent statistical analysis of Mirena Intrauterine System Timing of Insertion: A Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01272960).
- MISTIEIndependent statistical analysis of Minimally Invasive Surgery and rtPA for Intracerebral Hemorrhage Evacuation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00224770).
- MITIGATEIndependent statistical analysis of Study of Montelukast on Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Mitigation of Major Hip Injury Due to Fall With a Smart Belt: Complete Statistical AnalysisIndependent statistical analysis of Mitigation of Major Hip Injury Due to Fall With a Smart Belt: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Mitigation of Postoperative Delirium in High-Risk Patients: Complete Statistical AnalysisIndependent statistical analysis of Mitigation of Postoperative Delirium in High-Risk Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05777187).
- MitoCKDIndependent statistical analysis of Mitochondria and Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03177798).
- MITRALIndependent statistical analysis of Mitral Implantation of TRAnscatheter vaLves: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02370511).
- MIVI-5Independent statistical analysis of Safety and Efficacy Study of Intravitreal Ocriplasmin in Subjects With AMD With Focal Vitreomacular Adhesion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Mixture of Liposomal Bupivacaine and Bupivacaine for TAP Block for Open Hysterectomy: Complete Statistical AnalysisIndependent statistical analysis of Mixture of Liposomal Bupivacaine and Bupivacaine for TAP Block for Open Hysterectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- MK-1006 Single Dose Study in Japanese Type 2 Diabetes Patients (MK-1006-005): Complete Statistical AnalysisIndependent statistical analysis of MK-1006 Single Dose Study in Japanese Type 2 Diabetes Patients (MK-1006-005): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- MK-3475 Immunotherapy in Endometrial Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of MK-3475 Immunotherapy in Endometrial Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02630823).
- MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infection (cIAI) (MK-7625A-035): Complete Statistical AnalysisIndependent statistical analysis of MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infection (cIAI) (MK-7625A-035): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- MK-8527 Single-Dose Trial in HIV-1 Infected Participants (MK-8527-004): Complete Statistical AnalysisIndependent statistical analysis of MK-8527 Single-Dose Trial in HIV-1 Infected Participants (MK-8527-004): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05494736).
- MK0431 (Sitagliptin) Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus (0431-055)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of MK0431 (Sitagliptin) Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus (0431-055)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MK0431A Comparative Study in Patients With Type 2 Diabetes (0431A-079)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of MK0431A Comparative Study in Patients With Type 2 Diabetes (0431A-079)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00482729).
- MK0462 5 mg, Sumatriptan 50 mg, and Placebo Comparison Study (0462-029): Complete Statistical AnalysisIndependent statistical analysis of MK0462 5 mg, Sumatriptan 50 mg, and Placebo Comparison Study (0462-029): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- MK0476 Study in Adult Patients With Acute Asthma (0476-322): Complete Statistical AnalysisIndependent statistical analysis of MK0476 Study in Adult Patients With Acute Asthma (0476-322): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00229970).
- MK0507A Clinical Study in Patients With Glaucoma and Ocular Hypertension (0507A-149)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of MK0507A Clinical Study in Patients With Glaucoma and Ocular Hypertension (0507A-149)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- MK0524B Bioequivalence Study (0524B-070): Complete Statistical AnalysisIndependent statistical analysis of MK0524B Bioequivalence Study (0524B-070): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00943124).
- MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery: Complete Statistical AnalysisIndependent statistical analysis of MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MKitIndependent statistical analysis of A Pilot Study Testing a Life Skills Application to Address Interpersonal Relationships in College: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- MLIndependent statistical analysis of Morning Light Treatment to Improve Glucose Metabolism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03188263).
- mLab App Plus: A Randomized Controlled Trial of a Mobile Health (mHealth) Intervention: Complete Statistical AnalysisIndependent statistical analysis of mLab App Plus: A Randomized Controlled Trial of a Mobile Health (mHealth) Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MLD10 in the Prevention of Migraine in Adults: Complete Statistical AnalysisIndependent statistical analysis of MLD10 in the Prevention of Migraine in Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02322333).
- mLIFEIndependent statistical analysis of The Mobile Lifestyle Intervention for Food and Exercise Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05176847).
- MLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of MLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02575339).
- MLN0264 in Previously Treated Asian Participants With Advanced Gastrointestinal Carcinoma or Metastatic or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Guanylyl Cyclase C: Complete Statistical AnalysisIndependent statistical analysis of MLN0264 in Previously Treated Asian Participants With Advanced Gastrointestinal Carcinoma or Metastatic or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Guanylyl Cyclase C: primary endpoint results, effect estimate…